Polpharma has announced the integration of its Dutch Bioceros subsidiary under the Polpharma Biologics banner, to become “a truly integrated CDMO, offering the complete spectrum of services from discovery to commercial supply.”
The company plans to retire the Bioceros name as it brings Bioceros and its proprietary cell line development platform CHOBC...




